Fifth Third Bancorp’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-540
Closed -$39K 2542
2020
Q4
$39K Sell
540
-112
-17% -$5.86K ﹤0.01% 1476
2020
Q3
$30K Sell
652
-7,037
-92% -$294K ﹤0.01% 1487
2020
Q2
$347K Sell
7,689
-731
-9% -$32.8K ﹤0.01% 712
2020
Q1
$324K Sell
8,420
-691
-8% -$31.8K ﹤0.01% 694
2019
Q4
$422K Buy
9,111
+11
+0.1% +$476 ﹤0.01% 693
2019
Q3
$371K Buy
9,100
+1,326
+17% +$57.3K ﹤0.01% 726
2019
Q2
$374K Buy
7,774
+2,018
+35% +$106K ﹤0.01% 722
2019
Q1
$360K Sell
5,756
-1,894
-25% -$130K ﹤0.01% 707
2018
Q4
$457K Sell
7,650
-3,128
-29% -$188K ﹤0.01% 635
2018
Q3
$695K Sell
10,778
-1,969
-15% -$110K ﹤0.01% 590
2018
Q2
$574K Sell
12,747
-5,317
-29% -$212K ﹤0.01% 657
2018
Q1
$561K Sell
18,064
-3,610
-17% -$119K ﹤0.01% 650
2017
Q4
$648K Buy
21,674
+6,333
+41% +$183K ﹤0.01% 609
2017
Q3
$506K Sell
15,341
-3,184
-17% -$110K ﹤0.01% 666
2017
Q2
$620K Sell
18,525
-2,655
-13% -$79.2K ﹤0.01% 628
2017
Q1
$613K Buy
+21,180
New +$525K ﹤0.01% 642
2016
Q3
Sell
-260
Closed -$4K 2411
2016
Q2
$4K Hold
260
﹤0.01% 2042
2016
Q1
$3K Buy
+260
New +$2.9K ﹤0.01% 2136
2014
Q3
Sell
-13
Closed 2589
2014
Q2
$0 Buy
+13
New +$103 ﹤0.01% 2573

Other funds holding BEAT

Fifth Third Bancorp's BEAT Position: Q1 2021 in Review

Fifth Third Bancorp sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 540 shares — an estimated $39K sold.

Fifth Third Bancorp first reported a position in BEAT in Q2 2014 and held it in 19 quarters. The position peaked at $695K in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Fifth Third Bancorp reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Fifth Third Bancorp sold 540 BioTelemetry, Inc. shares in Q1 2021, an estimated $39K.
  • Fifth Third Bancorp first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 19 quarters.
  • Fifth Third Bancorp's BioTelemetry, Inc. position peaked at $695K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Fifth Third Bancorp's 13F filing for Q1 2021, filed 7 May 2021.